News and Events
Here you will find the latest news related to NIOX MINO® and asthma management. Check back regularly, as our News and Events center is continually being updated.
Jun 18, 2015
Circassia takes control of Aerocrine
Nov 06, 2014
AEROCRINE AB RECEIVES US FDA MARKET CLEARANCE FOR NIOX VERO®
Nov 25, 2013
NIOX MINO®-09 cleared for commercialization in Japan
Aerocrine’s industry leading FeNO-measuring device NIOX MINO®-09 cleared for commercialization in Japan
Nov 14, 2013
New device helping to treat asthma
ITV, the largest commercial television network in the UK broadcasts how NIOX MINO® transforms life for asthma suffers. Colin Walker, 56, a North Yorkshire farmer says the device has changed his life.
Oct 11, 2013
First primary care trial supports FeNO-guided asthma treatment
A new randomised clinical trial shows lower incidence of asthma exacerbations and increased asthma control with Fractional exhaled Nitric Oxide (FeNO)-guided anti-inflammatory treatment.
Apr 04, 2013
Georgia Medicaid covers FeNO test as of January 1, 2013
Aerocrine announces that Georgia Medicaid joins 36 other states now reimbursing for FeNO testing in the U.S.
Aerocrine has confirmed that Georgia’s Medicaid program now covers payment for fractional exhaled nitric oxide (FeNO) measurement. Georgia has nearly 1.5 million Medicaid beneficiaries. With the addition of Georgia, FeNO is now covered by Medicaid in 37 states and the District of Columbia.
Feb 22, 2013
Get expert information about measuring airway inflammation
Allergist David M. Lang, MD, explains the importance of exhaled nitric oxide testing in assessing asthma.
Feb 20, 2013
Texas Medicaid will cover FeNO test beginning April 1
With the addition of Texas, Aerocrine's FeNO testing will be covered by Medicaid in 36 states plus the District of Columbia.
Dec 18, 2012
Watch a webinar on Measurement of FeNO Levels in Clinical Practice: A Guideline-Based Approach
Asthma expert Neal Jain, MD, FAAP, FAAAAI, discusses FeNO as an aid in clinical decision making.
Dec 05, 2012
A new study from Queens University Belfast, UK, demonstrates that FeNO is a good measure of adherence in adults.
FeNO - a perfect tool in detecting non-adherence
Oct 26, 2012
FeNO Testing: A New Biomarker for Inflammation Enhances Asthma Diagnosis and Management, by Kathy Rickard, MD
FeNO testing represents a shift in the way asthma is managed.
Oct 12, 2012
Join a webinar on: Measurement of FeNO: An Innovation in Asthma Management
Please join asthma expert Chirta Dinarka, MD, to learn about advancement in measuring allergic airway inflammation.
Oct 09, 2012
See the full list of FeNO Coverage
FeNO coverage has expanded to approximately 60% across all private and public sectors. Below is a listing of coverage: